Homeostasis Imbalance Process Ontology: a Study on COVID-19 Infectious Processes

Overview

Journal BMC Med Inform Decis Mak

Publisher Biomed Central

Specialty Medical Informatics

Date 2024 May 22

PMID 38778394

Authors

Yuki Yamagata

Tatsuya Kushida

Shuichi Onami

Hiroshi Masuya

Affiliations

Soon will be listed here.

Abstract

Background: One significant challenge in addressing the coronavirus disease 2019 (COVID-19) pandemic is to grasp a comprehensive picture of its infectious mechanisms. We urgently need a consistent framework to capture the intricacies of its complicated viral infectious processes and diverse symptoms.

Results: We systematized COVID-19 infectious processes through an ontological approach and provided a unified description framework of causal relationships from the early infectious stage to severe clinical manifestations based on the homeostasis imbalance process ontology (HoIP). HoIP covers a broad range of processes in the body, ranging from normal to abnormal. Moreover, our imbalance model enabled us to distinguish viral functional demands from immune defense processes, thereby supporting the development of new drugs, and our research demonstrates how ontological reasoning contributes to the identification of patients at severe risk.

Conclusions: The HoIP organises knowledge of COVID-19 infectious processes and related entities, such as molecules, drugs, and symptoms, with a consistent descriptive framework. HoIP is expected to harmonise the description of various heterogeneous processes and improve the interoperability of COVID-19 knowledge through the COVID-19 ontology harmonisation working group.

References

He Y, Yu H, Ong E, Wang Y, Liu Y, Huffman A . CIDO, a community-based ontology for coronavirus disease knowledge and data integration, sharing, and analysis. Sci Data. 2020; 7(1):181. PMC: 7293349. DOI: 10.1038/s41597-020-0523-6. View

Lin Y, He Y . Ontology representation and analysis of vaccine formulation and administration and their effects on vaccine immune responses. J Biomed Semantics. 2012; 3(1):17. PMC: 3639077. DOI: 10.1186/2041-1480-3-17. View

Ji D, Qin E, Xu J, Zhang D, Cheng G, Wang Y . Non-alcoholic fatty liver diseases in patients with COVID-19: A retrospective study. J Hepatol. 2020; 73(2):451-453. PMC: 7141624. DOI: 10.1016/j.jhep.2020.03.044. View

Smith B, Ashburner M, Rosse C, Bard J, Bug W, Ceusters W . The OBO Foundry: coordinated evolution of ontologies to support biomedical data integration. Nat Biotechnol. 2007; 25(11):1251-5. PMC: 2814061. DOI: 10.1038/nbt1346. View

Ashburner M, Ball C, Blake J, Botstein D, Butler H, Cherry J . Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet. 2000; 25(1):25-9. PMC: 3037419. DOI: 10.1038/75556. View

Kanehisa M, Furumichi M, Tanabe M, Sato Y, Morishima K . KEGG: new perspectives on genomes, pathways, diseases and drugs. Nucleic Acids Res. 2016; 45(D1):D353-D361. PMC: 5210567. DOI: 10.1093/nar/gkw1092. View

Lin A, Yamagata Y, Duncan W, Carmody L, Kushida T, Masuya H . A community effort for COVID-19 Ontology Harmonization. CEUR Workshop Proc. 2023; 3073:122-127. PMC: 10262777. View

Natale D, Arighi C, Blake J, Bona J, Chen C, Chen S . Protein Ontology (PRO): enhancing and scaling up the representation of protein entities. Nucleic Acids Res. 2016; 45(D1):D339-D346. PMC: 5210558. DOI: 10.1093/nar/gkw1075. View

Kohler S, Gargano M, Matentzoglu N, Carmody L, Lewis-Smith D, Vasilevsky N . The Human Phenotype Ontology in 2021. Nucleic Acids Res. 2020; 49(D1):D1207-D1217. PMC: 7778952. DOI: 10.1093/nar/gkaa1043. View

10.

Bello S, Shimoyama M, Mitraka E, Laulederkind S, Smith C, Eppig J . Disease Ontology: improving and unifying disease annotations across species. Dis Model Mech. 2018; 11(3). PMC: 5897730. DOI: 10.1242/dmm.032839. View

11.

Smith B, Ceusters W, Klagges B, Kohler J, Kumar A, Lomax J . Relations in biomedical ontologies. Genome Biol. 2005; 6(5):R46. PMC: 1175958. DOI: 10.1186/gb-2005-6-5-r46. View

12.

Schultze J, Aschenbrenner A . COVID-19 and the human innate immune system. Cell. 2021; 184(7):1671-1692. PMC: 7885626. DOI: 10.1016/j.cell.2021.02.029. View

13.

Gkoutos G, Green E, Mallon A, Blake A, Greenaway S, Hancock J . Ontologies for the description of mouse phenotypes. Comp Funct Genomics. 2008; 5(6-7):545-51. PMC: 2447424. DOI: 10.1002/cfg.430. View

14.

Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V . ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res. 2015; 44(D1):D1214-9. PMC: 4702775. DOI: 10.1093/nar/gkv1031. View

15.

Ostaszewski M, Mazein A, Gillespie M, Kuperstein I, Niarakis A, Hermjakob H . COVID-19 Disease Map, building a computational repository of SARS-CoV-2 virus-host interaction mechanisms. Sci Data. 2020; 7(1):136. PMC: 7200764. DOI: 10.1038/s41597-020-0477-8. View

16.

Federhen S . The NCBI Taxonomy database. Nucleic Acids Res. 2011; 40(Database issue):D136-43. PMC: 3245000. DOI: 10.1093/nar/gkr1178. View

17.

Yamagata Y, Yamada H . Ontological approach to the knowledge systematization of a toxic process and toxic course representation framework for early drug risk management. Sci Rep. 2020; 10(1):14581. PMC: 7471325. DOI: 10.1038/s41598-020-71370-7. View

18.

Cevik M, Tate M, Lloyd O, Maraolo A, Schafers J, Ho A . SARS-CoV-2, SARS-CoV, and MERS-CoV viral load dynamics, duration of viral shedding, and infectiousness: a systematic review and meta-analysis. Lancet Microbe. 2021; 2(1):e13-e22. PMC: 7837230. DOI: 10.1016/S2666-5247(20)30172-5. View

19.

Mungall C, Torniai C, Gkoutos G, Lewis S, Haendel M . Uberon, an integrative multi-species anatomy ontology. Genome Biol. 2012; 13(1):R5. PMC: 3334586. DOI: 10.1186/gb-2012-13-1-r5. View

20.

Diehl A, Meehan T, Bradford Y, Brush M, Dahdul W, Dougall D . The Cell Ontology 2016: enhanced content, modularization, and ontology interoperability. J Biomed Semantics. 2016; 7(1):44. PMC: 4932724. DOI: 10.1186/s13326-016-0088-7. View